Neuromodulation trials

Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acu

RecruitingNCT07413562Phase: NAStarted 2025-02-01

Summary

Currently, the treatment of cognitive dysfunction after acute TBI remains a challenge, and novel therapeutic methods are urgently needed. Median nerve stimulation (MNS) is a non-invasive neuromodulati

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
64 Years

Locations

Beijing Tiantan Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07413562